{"id":"n_hdderc4sb6skbnjlg6wq","seq":10352625,"kind":"article","title":"First FDA Breakthrough Therapy designation in PSMA PET imaging granted to Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer","url":"http://www.sydneysun.com/news/279428860/first-fda-breakthrough-therapy-designation-in-psma-pet-imaging-granted-to-cu-64-sar-bispsma-in-biochemical-recurrence-of-prostate-cancer","published":"2026-11-12T16:15:00Z","seen":"2026-11-12T16:33:50Z","lang":"en","source":{"id":"sydneysun.com","name":"sydneysun.com","domain":"sydneysun.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"story":"st_rczcaihv4rz3rdqhax6q","category":"health","category_p":0.7,"sentiment":"positive","tone":0.03,"political":0.07}